ReviewJournal of fungi (Basel, Switzerland)2025
A Review of the Biotechnological Potential of Cave Fungi: A Toolbox for the Future.
Review in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Characterization of fungal communities in Guánica State Forest caves utilizing internal transcribed spacer sequencing.Microbiology resource announcements · 2026Article
- Fungal Communities Associated with Wooden Coffins in a Prehistoric Burial Cave.Journal of fungi (Basel, Switzerland) · 2026Article
- Culturable mycota from Karst caves in Yunnan Province, China.IMA fungus · 2026Article
- Article
- Microbial Community Analysis and Environmental Association in Cave 6 of the Yungang Grottoes.Microorganisms · 2025Article
- Some Like It Rock 'N' Cold: Speleomycology of Ravništarka Cave (Serbia).Journal of fungi (Basel, Switzerland) · 2025Article
- Unveiling the Subterranean Symphony: A Comprehensive Study of Cave Fungi Revealed Through National Center for Biotechnology Sequences.Journal of fungi (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study of the intersection between biodiversity and biotechnology has revealed a rich source of innovations. Fungi, with their vast range of morphologies and lifestyles, thrive in various habitats, including caves. With impressive metabolic characteristics, they play a key role in producing essential biotechnological compounds for various economic sectors. This paper aims to consolidate evidence on the biotechnological potential of fungi isolated from caves, highlighting the urgency of conserving and exploring these ecosystems. For this purpose, we conducted a comprehensive literature search using scientific databases (SciELO, Medline Complete, Medline/PubMed, Web of Science, Scopus (Elsevier), and Google Scholar). We adopted an interdisciplinary approach by collecting information from 22 papers published between 2013 and 2024. Based on these data, our survey revealed broad potential, including antimicrobial compounds, antioxidants, antitumor agents, enzymes, and organic acids. We emphasize that accurately identifying and depositing fungal isolates in reference collections are crucial for reliable research and effective industrial applications, driving metabolic bioactivity and the production of substances with the potential to inhibit pathogens. Conserving and protecting the cave environment is imperative, considering its continuous potential for discovery and contribution to scientific advancement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.